Prevalence of Hepatic Encephalopathy from a Commercial Medical Claims Database in the United States
Table 4
Serum ammonia levels in patients with HE.
Serum ammonia level range (μmol/L)
Number of patients (%) with serum ammonia
Cumulative estimated number of patients with serum ammonia > corresponding level range in 2018
≤ Corresponding level range
> Corresponding level range
0–10
6 (0.05)
11,107 (99.9)
201,749
11–20
48 (0.43)
11,059 (99.5)
200,877
21–30
258 (2.32)
10,801 (97.2)
196,191
31–40
563 (5.07)
10,238 (92.1)
185,964
41–50
879 (7.91)
9359 (84.2)
169,998
51–60
1088 (9.79)
8271 (74.4)
150,235
61–70
1127 (10.14)
7144 (64.3)
129,764
71–80
1153 (10.38)
5991 (53.9)
108,821
81–90
1102 (9.92)
4889 (44.0)
88,804
91–100
939 (8.45)
3950 (35.5)
71,748
101–110
794 (7.14)
3156 (28.4)
57,326
111–120
628 (5.65)
2528 (22.7)
45,919
121–130
548 (4.93)
1980 (17.8)
35,965
131–140
411 (3.70)
1569 (14.1)
28,500
141–150
332 (2.99)
1237 (11.1)
22,469
151–160
277 (2.49)
960 (8.6)
17,438
161–170
203 (1.83)
757 (6.8)
13,750
171–180
192 (1.73)
565 (5.1)
10,263
181–190
141 (1.27)
424 (3.8)
7702
191–200
97 (0.87)
327 (2.9)
5940
Total
11,113
N/A
N/A
Percentage of patients with levels greater than or equal to the of cirrhosis patients with HE in 2018, estimated as . HE: hepatic encephalopathy; N/A: not applicable.
